Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, P. R. China.
Clinical Center of Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, P. R. China.
Sci Rep. 2017 Aug 21;7(1):8967. doi: 10.1038/s41598-017-09271-5.
Recent evidence shows the emerging roles of promoter-targeting endogenous microRNAs (miRNAs) in regulating gene transcription. However, miRNAs affecting the transcription of matrix metalloproteinase 14 (MMP-14) in gastric cancer remain unknown. Herein, through integrative mining of public datasets, we identified the adjacent targeting sites of Yin Yang 1 (YY1) and miRNA-584-3p (miR-584-3p) within MMP-14 promoter. We demonstrated that YY1 directly targeted the MMP-14 promoter to facilitate its expression in gastric cancer cells. In contrast, miR-584-3p recognized its complementary site within MMP-14 promoter to suppress its expression. Mechanistically, miR-584-3p interacted with Argonaute 2 to recruit enhancer of zeste homolog 2 and euchromatic histone lysine methyltransferase 2, resulting in enrichment of repressive epigenetic markers and decreased binding of YY1 to MMP-14 promoter. miR-584-3p inhibited the in vitro and in vivo tumorigenesis and aggressiveness of gastric cancer cells through repressing YY1-facilitated MMP-14 expression. In clinical gastric cancer tissues, the expression of YY1 and miR-584-3p was positively or negatively correlated with MMP-14 levels. In addition, miR-584-3p and YY1 were independent prognostic factors associated with favorable and unfavorable outcome of gastric cancer patients, respectively. These data demonstrate that miR-584-3p directly targets the MMP-14 promoter to repress YY1-facilitated MMP-14 expression and inhibits the progression of gastric cancer.
最近的证据表明,启动子靶向内源性 microRNA(miRNA)在调节基因转录中发挥着新兴作用。然而,miRNA 如何影响胃癌中基质金属蛋白酶 14(MMP-14)的转录仍不清楚。在此,我们通过整合公共数据集的挖掘,鉴定出 YY1 和 miRNA-584-3p(miR-584-3p)在 MMP-14 启动子内的相邻靶向位点。我们证明 YY1 直接靶向 MMP-14 启动子,促进其在胃癌细胞中的表达。相比之下,miR-584-3p 识别 MMP-14 启动子内的互补位点,抑制其表达。在机制上,miR-584-3p 与 Argonaute 2 相互作用,招募 Enhancer of zeste homolog 2 和 euchromatic histone lysine methyltransferase 2,导致抑制性表观遗传标记物的富集和 YY1 与 MMP-14 启动子的结合减少。miR-584-3p 通过抑制 YY1 促进的 MMP-14 表达,抑制胃癌细胞的体外和体内肿瘤发生和侵袭能力。在临床胃癌组织中,YY1 和 miR-584-3p 的表达与 MMP-14 水平呈正相关或负相关。此外,miR-584-3p 和 YY1 是分别与胃癌患者有利和不利预后相关的独立预后因素。这些数据表明,miR-584-3p 直接靶向 MMP-14 启动子,抑制 YY1 促进的 MMP-14 表达,并抑制胃癌的进展。